Search
Adriforant
go.drugbank.com/drugs/DB15027InvestigationalAdriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
Tiemonium iodide
go.drugbank.com/drugs/DB13666ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersTesidolumab
go.drugbank.com/drugs/DB11926InvestigationalTesidolumab has been used in trials studying the treatment of Geographic Atrophy, Non-infectious Panuveitis, Exudative Macular Degeneration, Non-infectious Posterior Uveitis, and Age-related Macular Degeneration
(R)-Propafenone
go.drugbank.com/drugs/DB19162InvestigationalPropafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
Synonyms: (R)-propafenone, (+)-(r)-propafenone(S)-Propafenone
go.drugbank.com/drugs/DB15410Investigational(S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
Indobufen
go.drugbank.com/drugs/DB12545InvestigationalIndobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSZavolosotine
go.drugbank.com/drugs/DB21531ExperimentalZavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.
Branosotine
go.drugbank.com/drugs/DB21674ExperimentalBranosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.
Pratosartan
go.drugbank.com/drugs/DB20100ExperimentalPratosartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Pratosartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).
Ripisartan
go.drugbank.com/drugs/DB20229ExperimentalRipisartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Ripisartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).